BXRX - Baudax Bio GAAP EPS of -$12.33 misses by $2.57 revenue of $0.31M
- Baudax Bio press release ( NASDAQ: BXRX ): Q4 GAAP EPS of -$12.33 misses by $2.57 .
- Revenue of $0.31M (-22.5% Y/Y).
-
As of December 31, 2022, Baudax had cash and cash equivalents of $5.3 million.
- Shares +3.36% PM.
For further details see:
Baudax Bio GAAP EPS of -$12.33 misses by $2.57, revenue of $0.31M